Robeco Institutional Asset Management B.V. Lowers Holdings in CME Group Inc. (NASDAQ:CME)

Robeco Institutional Asset Management B.V. trimmed its holdings in CME Group Inc. (NASDAQ:CME) by 4.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 151,547 shares of the financial services provider’s stock after selling 6,786 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CME Group were worth $33,439,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Capital International Investors boosted its stake in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. increased its position in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the last quarter. M&G Plc purchased a new stake in CME Group during the first quarter valued at $156,631,000. Assenagon Asset Management S.A. lifted its position in CME Group by 577.9% during the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after purchasing an additional 550,133 shares during the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CME. Morgan Stanley increased their price target on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a report on Thursday, October 17th. Keefe, Bruyette & Woods lifted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Citigroup lifted their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Finally, Barclays increased their target price on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $222.73.

CME Group Stock Up 0.9 %

Shares of NASDAQ CME opened at $225.19 on Wednesday. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The firm has a market capitalization of $81.09 billion, a price-to-earnings ratio of 23.68, a PEG ratio of 5.62 and a beta of 0.55. The stock has a 50 day moving average price of $221.24 and a 200 day moving average price of $209.67. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the prior year, the business earned $2.25 EPS. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. Sell-side analysts expect that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.04%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.